Visual Function and Patient Satisfaction in Glaucoma or Ocular Hypertensive Patients Undergoing Simultaneous Cataract Surgery and i-Stent Implantation

Sponsor
Clínica Rementería (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05392738
Collaborator
(none)
45
1
23.4
1.9

Study Details

Study Description

Brief Summary

New extended depth of focus intraocular lenses (IOLs) are being used in a broader spectrum of patients than trifocal IOLs. The purpose of this study is to evaluate visual improvement after cataract surgery in patients with glaucoma or ocular hypertension undergoing simultaneous cataract surgery with i-Stent implantation with the implantation of a Vivity IOL. Results will be compared with a group of glaucoma or ocular hypertension undergoing isolated cataract surgery with Vivity implantation, as well as with patients with no pathology undergoing cataract surgery and Vivity implantation

Condition or Disease Intervention/Treatment Phase
  • Device: I-Stent implantation

Detailed Description

The purpose of this study is to report in detail visual function and patient satisfaction, as well as the need for spectacle correction, in patients with glaucoma and ocular hypertension undergoing cataract surgery with bilateral implantation of an extended depth of focus IOL, the Vivity IOL. The study also seeks to determine if there are differences in the speed of visual improvement between patients undergoing isolated cataract surgery and patients undergoing simultaneous i-Stent implantation. Results will also be compared with a group of patients with no ocular pathology undergoing cataract surgery with Vivity implantation.

Patients will be asked to join the study once the type of surgery (isolated phacoemulsification versus phacoemulsification combined with i-Stent implantation) and the type of lens to be implanted (monofocal, EDoF, trifocal) has been agreed between ophthalmologist and patient. Therefore, inclusion in the study will have no influence on surgical indication.

Once informed consent has been signed, the patient will be included in the study.

Explorations specific for the study will be performed 3 and 12 months after surgery and include:

Defocus curves Contrast sensitivity Self-reported photic phenomena Need for spectacle correction Satisfaction measured with the Catquest SF9 questionnaire

Besides study-specific procedures, the following explorations which are standard of care will be performed one day, one week and one month after surgery:

Uncorrected binocular visual acuity for distance, intermediate and near distances Monocular distance corrected and uncorrected visual acuity Residual subjective refraction Slit-lamp examination Intraocular pressure and number of hypotensive drugs required Description of any intra- or postsurgical complications

Study Design

Study Type:
Observational
Anticipated Enrollment :
45 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Visual Function and Patient Satisfaction in Glaucoma or Ocular Hypertensive Patients Undergoing Simultaneous Cataract Surgery and i-Stent Implantation
Actual Study Start Date :
Jun 20, 2022
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Vivity with i-Stent

Patients with Glaucoma or Ocular Hypertension undergoing simultaneous cataract and i-Stent implantation, with Vivity intraocular lens

Device: I-Stent implantation
I-Stent implantation

Glaucoma with Vivity

Patients with Glaucoma or Ocular Hypertension undergoing isolated phacoemulsification with Vivity intraocular lens

Healthy with Vivity

Patients with undergoing isolated phacoemulsification with Vivity intraocular lens

Outcome Measures

Primary Outcome Measures

  1. Binocular uncorrected distance visual acuity [Three months after surgery]

    Binocular uncorrected distance visual acuity

  2. Binocular uncorrected intermediate visual acuity [Three months after surgery]

    Binocular uncorrected intermediate visual acuity

  3. Binocular uncorrected near visual acuity [Three months after surgery]

    Binocular uncorrected near visual acuity

Secondary Outcome Measures

  1. Binocular uncorrected distance visual acuity [One month after surgery]

    Binocular uncorrected distance visual acuity

  2. Binocular uncorrected intermediate visual acuity [One month after surgery]

    Binocular uncorrected intermediate visual acuity

  3. Binocular uncorrected near visual acuity [One month after surgery]

    Binocular uncorrected near visual acuity

  4. Contrast sensitivity [Three months after surgery]

    Contrast sensitivity

  5. Need for spectacle correction [Three months after surgery]

    Need for spectacle correction

  6. Patient satisfaction [Three months after surgery]

    Patient satisfaction evaluated with the Catquest SF9 questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Bilateral cataract surgery with Vivity implantation with or without i_STent implantation

Exclusion Criteria: Ocular disease other than glaucoma

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clínica Rementería Madrid Spain 28010

Sponsors and Collaborators

  • Clínica Rementería

Investigators

  • Principal Investigator: Beatriz Puerto, MD, Clínica Rementería

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Clínica Rementería
ClinicalTrials.gov Identifier:
NCT05392738
Other Study ID Numbers:
  • 22/265-O_P
First Posted:
May 26, 2022
Last Update Posted:
Jul 20, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 20, 2022